Global COVID-19 RT-PCR Test Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global COVID-19 RT-PCR Test market size will reach US$ million by 2031.
RT-PCR (Reverse Transcription-Polymerase Chain Reaction) is a technique that combines the Reverse transcription of RNA (RT) with the polymerase Chain Reaction (PCR) of CDNA. Rt-pcr is a sensitive and versatile technique, which can be used to detect gene expression level, RNA virus content and CDNA sequence of specific genes in cells / tissues.
United States market for COVID-19 RT-PCR Test is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for COVID-19 RT-PCR Test is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for COVID-19 RT-PCR Test is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key COVID-19 RT-PCR Test players cover Bio-Rad Laboratories, Thermo Fisher Scientific, Qiagen N.V., Abbott Laboratories, Roche, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “COVID-19 RT-PCR Test Industry Forecast” looks at past sales and reviews total world COVID-19 RT-PCR Test sales in 2024, providing a comprehensive analysis by region and market sector of projected COVID-19 RT-PCR Test sales for 2025 through 2031. With COVID-19 RT-PCR Test sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world COVID-19 RT-PCR Test industry.
This Insight Report provides a comprehensive analysis of the global COVID-19 RT-PCR Test landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on COVID-19 RT-PCR Test portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global COVID-19 RT-PCR Test market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for COVID-19 RT-PCR Test and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global COVID-19 RT-PCR Test.
This report presents a comprehensive overview, market shares, and growth opportunities of COVID-19 RT-PCR Test market by product type, application, key players and key regions and countries.
Segmentation by Type:
Consumables & Reagents
Instruments
Software & Services
Segmentation by Application:
Hospitals
Scientific Research
Biodiagnostics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bio-Rad Laboratories
Thermo Fisher Scientific
Qiagen N.V.
Abbott Laboratories
Roche
Agilent Technologies
bioMerieux S.A.
Fluidigm Corporation
Bioer
Biosynex
Esco
Analytik Jena
Techne
Please note: The report will take approximately 2 business days to prepare and deliver.
RT-PCR (Reverse Transcription-Polymerase Chain Reaction) is a technique that combines the Reverse transcription of RNA (RT) with the polymerase Chain Reaction (PCR) of CDNA. Rt-pcr is a sensitive and versatile technique, which can be used to detect gene expression level, RNA virus content and CDNA sequence of specific genes in cells / tissues.
United States market for COVID-19 RT-PCR Test is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for COVID-19 RT-PCR Test is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for COVID-19 RT-PCR Test is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key COVID-19 RT-PCR Test players cover Bio-Rad Laboratories, Thermo Fisher Scientific, Qiagen N.V., Abbott Laboratories, Roche, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “COVID-19 RT-PCR Test Industry Forecast” looks at past sales and reviews total world COVID-19 RT-PCR Test sales in 2024, providing a comprehensive analysis by region and market sector of projected COVID-19 RT-PCR Test sales for 2025 through 2031. With COVID-19 RT-PCR Test sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world COVID-19 RT-PCR Test industry.
This Insight Report provides a comprehensive analysis of the global COVID-19 RT-PCR Test landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on COVID-19 RT-PCR Test portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global COVID-19 RT-PCR Test market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for COVID-19 RT-PCR Test and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global COVID-19 RT-PCR Test.
This report presents a comprehensive overview, market shares, and growth opportunities of COVID-19 RT-PCR Test market by product type, application, key players and key regions and countries.
Segmentation by Type:
Consumables & Reagents
Instruments
Software & Services
Segmentation by Application:
Hospitals
Scientific Research
Biodiagnostics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bio-Rad Laboratories
Thermo Fisher Scientific
Qiagen N.V.
Abbott Laboratories
Roche
Agilent Technologies
bioMerieux S.A.
Fluidigm Corporation
Bioer
Biosynex
Esco
Analytik Jena
Techne
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
103 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 COVID-19 RT-PCR Test Market Size by Player
- 4 COVID-19 RT-PCR Test by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global COVID-19 RT-PCR Test Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
